Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta‐epidemiological study of randomized trials

por Hulshof, Tessa A., Zuidema, Sytse U., van Meer, Peter J.K., Gispen‐de Wied, Christine C., Luijendijk, Hendrika J.
Publicado 2018

Levelling the Translational Gap for Animal to Human Efficacy Data

por Ferreira, Guilherme S., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., van Meer, Peter J. K.
Publicado 2020

A standardised framework to identify optimal animal models for efficacy assessment in drug development

por S. Ferreira, Guilherme, Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., Gispen-de Wied, Christine C., Schellekens, Huub, van Meer, Peter J. K.
Publicado 2019

Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development

por Ferreira, Guilherme S., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., Gispen-de Wied, Christine C., Schellekens, Huub, van Meer, Peter J. K.
Publicado 2019

Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs

por Ferreira, Guilherme S., Dijkstra, Francis M., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Schellekens, Huub, Moors, Ellen H. M., van Meer, Peter J. K., Stuurman, Frederik E., van Gerven, Joop M. A.
Publicado 2023

Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency

por Dekker, Marieke J. H. J., de Vries, Sieta T., Versantvoort, Carolien H. M., Drost-van Velze, Ellen G. E., Bhatt, Mansi, van Meer, Peter J. K., Havinga, Ineke K., Gispen-de Wied, Christine C., Mol, Peter G. M.
Publicado 2021